{"id":"https://openalex.org/W2591427437","doi":"https://doi.org/10.1111/bjh.14534","title":"A phase 1/2 trial of ublituximab, a novel anti\u2010 CD 20 monoclonal antibody, in patients with B\u2010cell non\u2010Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab","display_name":"A phase 1/2 trial of ublituximab, a novel anti\u2010 CD 20 monoclonal antibody, in patients with B\u2010cell non\u2010Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab","publication_year":2017,"publication_date":"2017-02-21","ids":{"openalex":"https://openalex.org/W2591427437","doi":"https://doi.org/10.1111/bjh.14534","mag":"2591427437","pmid":"https://pubmed.ncbi.nlm.nih.gov/28220479","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5412890"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.14534","doi":"https://doi.org/10.1111/bjh.14534","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14534","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14534","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14534","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008086243","display_name":"Ahmed Sawas","orcid":"https://orcid.org/0000-0003-2448-0144","observed_orcids":["https://orcid.org/0000-0003-2448-0144"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Sawas","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042998970","display_name":"Charles Michael Farber","orcid":"https://orcid.org/0000-0002-2753-6986","observed_orcids":["https://orcid.org/0000-0002-2753-6986"]},"institutions":[{"id":"https://openalex.org/I2802646204","display_name":"Morristown Medical Center","ror":"https://ror.org/03m6tev69","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802646204","https://openalex.org/I67339987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles M. Farber","raw_affiliation_strings":["Carol G. Simon Cancer Center, Morristown, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carol G. Simon Cancer Center, Morristown, NJ, USA","institution_ids":["https://openalex.org/I2802646204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025465348","display_name":"Marshall T. Schreeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118515","display_name":"Clearview Cancer Institute","ror":"https://ror.org/020cs7q41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210118515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marshall T. Schreeder","raw_affiliation_strings":["Clearview Cancer Institute, Huntsville, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clearview Cancer Institute, Huntsville, AL, USA","institution_ids":["https://openalex.org/I4210118515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074000911","display_name":"Mazen Y. Khalil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157218","display_name":"St. Bernards Clopton Clinic","ror":"https://ror.org/05dbj3194","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mazen Y. Khalil","raw_affiliation_strings":["St. Bernards Clopton Clinic, Jonesboro, AR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Bernards Clopton Clinic, Jonesboro, AR, USA","institution_ids":["https://openalex.org/I4210157218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035164790","display_name":"Daruka Mahadevan","orcid":"https://orcid.org/0000-0002-2991-0361","observed_orcids":["https://orcid.org/0000-0002-2991-0361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daruka Mahadevan","raw_affiliation_strings":["The West Clinic, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The West Clinic, Memphis, TN, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101491956","display_name":"Changchun Deng","orcid":"https://orcid.org/0000-0001-9372-6086","observed_orcids":["https://orcid.org/0000-0001-9372-6086"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Changchun Deng","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer E. Amengual","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043591208","display_name":"Petros G. Nikolinakos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166083","display_name":"University Cancer and Blood Center","ror":"https://ror.org/05wqwpj81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210166083"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Petros G. Nikolinakos","raw_affiliation_strings":["University Cancer and Blood Center, Athens, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Cancer and Blood Center, Athens, GA, USA","institution_ids":["https://openalex.org/I4210166083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016348831","display_name":"Jill Kolesar","orcid":"https://orcid.org/0000-0003-1802-6439","observed_orcids":["https://orcid.org/0000-0003-1802-6439","https://orcid.org/0000-0001-8575-4546"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill M. Kolesar","raw_affiliation_strings":["Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075492015","display_name":"John G. Kuhn","orcid":"https://orcid.org/0000-0002-7359-8643","observed_orcids":["https://orcid.org/0000-0002-7359-8643"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John G. Kuhn","raw_affiliation_strings":["University of Texas Health Science Center at San Antonio, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at San Antonio, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074058246","display_name":"Peter Sportelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Sportelli","raw_affiliation_strings":["TG Therapeutics Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics Inc., New York, NY, USA","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007928824","display_name":"Hari P. Miskin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hari P. Miskin","raw_affiliation_strings":["TG Therapeutics Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics Inc., New York, NY, USA","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University Medical Center, New York, NY, USA","institution_ids":["https://openalex.org/I2799503643"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5002126535"],"corresponding_institution_ids":["https://openalex.org/I2799503643"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":7.4938,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.98148949,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"177","issue":"2","first_page":"243","last_page":"253"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6273999810218811,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6273999810218811,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.3707999885082245,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ublituximab","display_name":"ublituximab","score":1.0},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.996999979019165},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/rituximab-refractory-disease","display_name":"rituximab-refractory disease","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7639999985694885},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.6919999718666077},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.8489999771118164},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.746999979019165},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.460999995470047},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9760000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8609703779220581},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7567713260650635},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7487838268280029},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6747519969940186},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6094862222671509},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5787020921707153},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5638871788978577},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5563924908638},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4960564076900482},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4703376889228821},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.46526244282722473},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.4129073917865753},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3746052384376526},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3350076675415039},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.26975467801094055},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/bjh.14534","doi":"https://doi.org/10.1111/bjh.14534","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14534","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14534","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5412890","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5412890","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Haematol","raw_type":"Text"},{"id":"pmid:28220479","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28220479","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1111/bjh.14534","doi":"https://doi.org/10.1111/bjh.14534","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.14534","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.14534","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320313971","display_name":"TG Therapeutics","ror":"https://ror.org/00pwykz63"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2591427437.pdf","grobid_xml":"https://content.openalex.org/works/W2591427437.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W1576880656","https://openalex.org/W1935886040","https://openalex.org/W1965205681","https://openalex.org/W1966016310","https://openalex.org/W1971342791","https://openalex.org/W1979300931","https://openalex.org/W1986574524","https://openalex.org/W1986976471","https://openalex.org/W1988795495","https://openalex.org/W2000365588","https://openalex.org/W2003089766","https://openalex.org/W2016973656","https://openalex.org/W2042483573","https://openalex.org/W2048260069","https://openalex.org/W2066564017","https://openalex.org/W2073019775","https://openalex.org/W2074262644","https://openalex.org/W2075141373","https://openalex.org/W2086121127","https://openalex.org/W2086296392","https://openalex.org/W2093394631","https://openalex.org/W2097876567","https://openalex.org/W2108669049","https://openalex.org/W2109687784","https://openalex.org/W2119684871","https://openalex.org/W2121227413","https://openalex.org/W2124575836","https://openalex.org/W2129041705","https://openalex.org/W2133201432","https://openalex.org/W2134074056","https://openalex.org/W2135525316","https://openalex.org/W2135668465","https://openalex.org/W2142099365","https://openalex.org/W2143901303","https://openalex.org/W2153665789","https://openalex.org/W2156522119","https://openalex.org/W2163450464","https://openalex.org/W2183104710","https://openalex.org/W2233614027","https://openalex.org/W2264636885","https://openalex.org/W2284624791","https://openalex.org/W2536068306","https://openalex.org/W2573756203","https://openalex.org/W2598989869","https://openalex.org/W3041047318","https://openalex.org/W4211249224"],"related_works":["https://openalex.org/W2602916029","https://openalex.org/W2565099910","https://openalex.org/W2582321885","https://openalex.org/W2763836376","https://openalex.org/W2795482501","https://openalex.org/W2079365532","https://openalex.org/W2091210765","https://openalex.org/W2264636885","https://openalex.org/W2004961788","https://openalex.org/W2028943076"],"abstract_inverted_index":{"This":[0],"phase":[1],"1/2":[2],"study":[3],"evaluated":[4],"the":[5],"safety,":[6],"pharmacokinetic":[7],"behavior":[8],"and":[9,54,61,90,132,147,175,181,188,193],"anti-tumour":[10],"activity":[11],"of":[12,41,45,98,173],"ublituximab,":[13],"a":[14,96,191],"unique":[15],"type":[16],"I,":[17],"chimeric,":[18],"glycoengineered":[19],"anti-CD20":[20],"monoclonal":[21],"antibody,":[22],"in":[23,49,58,190],"rituximab-relapsed":[24],"or":[25,33,105],"-refractory":[26],"patients":[27,84,159],"with":[28,85],"B-cell":[29],"non-Hodgkin":[30],"lymphoma":[31],"(B-NHL)":[32],"chronic":[34],"lymphocytic":[35],"leukaemia":[36],"(CLL).":[37],"Induction":[38],"therapy":[39],"(doses":[40],"450-1200":[42],"mg)":[43],"consisted":[44],"4":[46],"weekly":[47,56],"infusions":[48,57],"cycle":[50],"1":[51,60],"for":[52,63,78,157],"NHL":[53],"3":[55,76,99],"cycles":[59,71],"2":[62,81],"CLL.":[64],"Patients":[65],"received":[66],"ublituximab":[67],"maintenance":[68],"monthly":[69],"during":[70],"3-5,":[72],"then":[73],"once":[74],"every":[75],"months":[77,180],"up":[79],"to":[80],"years.":[82],"Enrolled":[83],"B-NHL":[86],"(n":[87,92,160],"=":[88,93,161],"27)":[89],"CLL":[91],"8)":[94],"had":[95],"median":[97],"prior":[100],"therapies.":[101],"No":[102],"dose-limiting":[103],"toxicities":[104],"unexpected":[106],"adverse":[107],"events":[108],"(AEs)":[109],"occurred.":[110],"The":[111,153],"most":[112],"common":[113],"AEs":[114,140],"were":[115,141,178],"infusion-related":[116],"reactions":[117],"(40%;":[118],"grade":[119,124,129,135,144,150],"3/4,":[120,125,130,136,145,151],"0%);":[121,131],"fatigue":[122],"(37%;":[123],"3%);":[126],"pyrexia":[127],"(29%;":[128],"diarrhoea":[133],"(26%;":[134],"0%).":[137],"Common":[138],"haematological":[139],"neutropenia":[142],"(14%;":[143],"14%)":[146],"anaemia":[148],"(11%;":[149],"6%).":[152],"overall":[154],"response":[155,174],"rate":[156],"evaluable":[158],"31)":[162],"was":[163,186],"45%":[164],"(13%":[165],"complete":[166],"responses,":[167],"32%":[168],"partial":[169],"responses).":[170],"Median":[171],"duration":[172],"progression-free":[176],"survival":[177],"9\u00b72":[179],"7\u00b77":[182],"months,":[183],"respectively.":[184],"Ublituximab":[185],"well-tolerated":[187],"efficacious":[189],"heterogeneous":[192],"highly":[194],"rituximab-pre-treated":[195],"patient":[196],"population.":[197]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-03T00:00:00"}